BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

BIOTECHNOLOGY INDUSTRY ORGANIZATION — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

BIOTECHNOLOGY INDUSTRY ORGANIZATION

via THE WERNER GROUP

2nd Quarter (Apr 1 - June 30) · 2008Posted Jul 15, 2008Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: BIOTECHNOLOGY INDUSTRY ORGANIZATION
Location: District of Columbia · United States of America

Registrant

Firm: THE WERNER GROUP
Description: public policy consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
LobbyistsMICHAEL WERNER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.